Scholar Rock (SRRK)
(Delayed Data from NSDQ)
$9.15 USD
-0.13 (-1.40%)
Updated Jul 29, 2024 04:00 PM ET
After-Market: $9.13 -0.02 (-0.22%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Brokerage Reports
0 items in cart
Scholar Rock Holding Corporation [SRRK]
Reports for Purchase
Showing records 41 - 60 ( 134 total )
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Scholar Has the Brains, Going After the Brawn
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Scholar Graduates to Master, on to Doctorate
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Apitegromab Continues to Deliver Benefit at 36 Months, Strengthening Its Potential in SMA
Provider: H.C. Wainwright & Co., Inc.
Analyst: MALDONADO A
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
ASCO 2023 Abstract Roundup for Covered Companies
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Upcoming Data From Apitegromab and SRK-181, Poised to Continue Pipeline Momentum
Provider: H.C. Wainwright & Co., Inc.
Analyst: MALDONADO A
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
At 3 years, will the Scholar graduate to Master?
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Updates Across Pipeline Add to Positive Profiles For Apitegromab and SRK-181; Reit. Buy and $30 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: MALDONADO A
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Crouching TOPAZ, hidden DRAGON: glimpses of data throughout ?23
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
A TGF Platform That Continues to Deepen; Reit. Buy and $30 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: MALDONADO A
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
SRK-181 Shows New Signals of Positive Momentum During SITC ?22
Provider: H.C. Wainwright & Co., Inc.
Analyst: MALDONADO A
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Apitegromab Additional QOL Data Ahead of SAPPHIRE Main Event
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
HEALTHCARE - The Week Ahead in Life Sciences
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D